My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2001-072
CBCC
>
Resolutions
>
2000's
>
2001
>
2001-072
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
2/7/2017 12:06:43 PM
Creation date
9/30/2015 5:11:33 PM
Metadata
Fields
Template:
Resolutions
Resolution Number
2001-072
Approved Date
08/07/2001
Resolution Type
Bonds
Entity Name
Dodgertown
Subject
Revenue Bonds Spring Training Facility Series 2011
Spring Training Facility
Area
Dodgertown
Archived Roll/Disk#
2745
Supplemental fields
SmeadsoftID
2584
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
67
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
r � <br /> replenishment of any such cash amounts. Draws on all alternative credit instruments on <br /> which there is available coverage shall be made on a pro rata basis (calculated by reference <br /> to coverage then available under each such alternative credit instrument) after applying <br /> available cash and investments in the reserve fund. Repayment of Policy Costs and <br /> reimbursement of amounts with respect to alternative credit instruments shall be made on a <br /> pro rata basis (calculated by reference to the coverage then available under each such <br /> alternative credit instrument) prior to replenishment of any cash draws on the reserve fund. <br /> 9. The Authorizing Document shall not be modified or amended without the prior written <br /> consent of the Insurer. <br /> 10. The Authorizing Document shall not be discharged until all Policy Costs owing to Financial <br /> Guaranty shall have been paid in full. <br /> 11. As security for the Issuer's repayment obligations with respect to the Reserve Policy, to the <br /> extent that the Authorizing Document pledges or grants a security interest in any revenues <br /> or collateral of the Issuer (or other obligor) as security for the Bonds, the Issuer hereby <br /> pledges and grants a security interest in all such revenues and collateral, subordinate only <br /> to that of the Bondholders. The Issuer shall evidence the Insurer's pledge or security <br /> interest by the filing of appropriate Uniform Commercial Code financing and continuation <br /> statements. <br /> 12. The rate covenant and the additional bonds test (in each case, if applicable) in the <br /> Authorizing Document shall be calculated with at least one times coverage of the Issuer's <br /> obligations with respect to repayment of Policy Costs then due and owing. Furthermore, no <br /> additional bonds may be issued under the Authorizing Document without the Insurer's <br /> prior written consent if any Policy Costs are past due and owing to the Insurer. <br /> 13. The Issuer shall provide Financial Guaranty with the following information: <br /> (a) Budget for each year and annual audited financial statements, within 180 days after <br /> the end of its fiscal year. <br /> (b) Official statement or similar disclosure document, if any, prepared in connection <br /> with the issuance of additional debt. <br /> (c) Notice of the redemption, other than mandatory sinking fund redemption, of any of <br /> the Bonds. <br /> (d) Such additional information as Financial Guaranty may reasonably request from <br /> time to time. <br /> 14. Notices to the Insurer shall be sent to the following address (or such other address as the <br /> Insurer may designate in writing): Financial Guaranty Insurance Company, 115 Broadway, <br /> New York, New York 10006, Attention: Risk Management. <br /> 15. This Agreement may be executed in counterparts, each of which alone and all of which <br /> together shall be deemed one original Agreement. <br /> 16. If any one or more of the agreements, provisions or terms of this Agreement shall be for <br /> any reason whatsoever held invalid, then such agreements, provisions or terms shall be <br /> C-2 <br />
The URL can be used to link to this page
Your browser does not support the video tag.